{
  "ticker": "IMU",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02969768",
  "id": "02969768",
  "pages": 12,
  "price_sensitive": true,
  "date": "20250716",
  "time": "1036",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250716/pdf/06lv9l77343kcy.pdf",
  "summary": "### **Capital Raising Announcement Summary**  \n\n- **Structure**: $22.5M **Placement** (closed) + $15M **Share Purchase Plan (SPP)** (open).  \n- **Pricing**: $0.33/share (~19.6\u201322.4% discount to VWAP/last close).  \n- **Attaching Options**: 3 free options per 4 new shares (exercise $0.43, expiry 30 Mar 2026).  \n- **Piggyback Options**: 1 free option per Attaching Option exercised (exercise $0.86, expiry 30 Jun 2028).  \n- **Use of Proceeds**: Fund **azer-cel clinical program** through pivotal trial (CY26), extend cash runway to **mid-CY27**.  \n- **Post-raise Cash (pro forma)**: $64M (incl. $5.8M R&D rebate, assumes full SPP uptake).  \n- **Additional Potential Funding**: Up to **$36.6M** if all options exercised.  \n\n### **Key Dates**  \n- **SPP Record Date**: 15 Jul 2025.  \n- **Placement Settlement**: 24 Jul 2025.  \n- **SPP Close**: 18 Aug 2025.  \n- **SPP/Options Allotment**: 25 Aug 2025.  \n- **Piggyback Options Cut-off**: 30 Mar 2026.  \n\n*(Omitted: Background details, management quotes, non-material terms.)*",
  "usage": {
    "prompt_tokens": 6005,
    "completion_tokens": 323,
    "total_tokens": 6328,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-16T01:45:48.808569"
}